Form 4: Humana Executive David Dintenfass Reports Stock Transactions

Humana executive David Dintenfass disposed of 261 shares to cover tax liabilities from vested restricted stock units and holds 51,389 stock options.

Summary

• David Dintenfass, President of Enterprise Growth at Humana Inc., reported a transaction involving the company's stock.
• On December 15, 2024, Mr. Dintenfass disposed of 261 shares of Humana common stock at a price of $271.675 per share.
• This disposal was to cover tax liabilities related to restricted stock units that vested on the same date.
• Following the transaction, Mr. Dintenfass directly owns 13,049 shares of Humana common stock.
• Mr. Dintenfass also holds 51,389 stock options, which were granted on February 21, 2024, and vest in three annual increments from February 21, 2025, to February 21, 2027.

Sentiment

Score: 5

Explanation: The document is a routine filing of stock transactions by an executive, which is neither positive nor negative for the company's performance.

Industry Context

This is a routine filing related to executive stock transactions and is common for publicly traded companies. It provides transparency into the holdings of company insiders.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider transactions.
• The vesting schedule of the stock options is typical for executive compensation packages.
• The tax liability payment through share disposal is a common method for handling restricted stock unit vesting.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine executive stock transaction.

Key Dates

Keywords

Humana, stock options, stock transaction, restricted stock units, executive, David Dintenfass, insider trading, Form 4